Diseases & Disorders
(G80)
IRS Verified
DX Registered
990 on File
3Q29 FOUNDATION
Financial strength (30%)
45/100
Reliability (20%)
40/100
Effectiveness (25%)
38/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The mission of the 3q29 Foundation is to create a path to treatment for chromosome 3q29 syndromes by funding research, increasing access to information and resources and building a community
Financial Overview — FY 2025
$38K
Total Revenue
$20K
Total Expenses
$134K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
0.0%
Fundraising Efficiency
N/A
Operating Reserve
81.64x
Liability-to-Asset
0.0%
Revenue Diversification
89.0%
Compared with Peers
FY 2025
Compared with 903 similar organizations
(United States, Diseases & Disorders, under $100K in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
0.0% | 79.5% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
69.9% | 7.5% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
30.1% | 0.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
81.6 mo | 21.4 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
89.0% | 99.4% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-74.3% | 2.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-54.7% | -4.2% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
48.3% | 13.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $38K | $20K | $134K | 0.0% | 0 |
| 2024 | $148K | $43K | $115K | 0.0% | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.